(Q43885598)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

Parameswaran Venugopal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

F Zorat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

V Shetty

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D Dutt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Lisak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Nascimben

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K Allampallam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Dar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A York

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Gezer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A Raza

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

881-894

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11843822%20AND%20SRC:MED&resulttype=core&format=json

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Angiogenesis in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Bone marrow angiogenesis and progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X

Apoptosis and its significance in MDS: controversies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03204.X